| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198 | DOUGLAS | USA | Cancer Biology Research | 000 | 7 | 10/20/2023 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = -$47,953 ) |
| 2023 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 000 | 6 | 6/29/2023 | NON-COMPETING CONTINUATION | -$375,089 |
| 2023 | 2022 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 987835 NEBRASKA MEDICAL CENTER | OMAHA | NE | 68198 | DOUGLAS | USA | Cancer Biology Research | 001 | 7 | 6/29/2023 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $327,136 |
|
| Issue Date FY: 2022 ( Subtotal = $465,304 ) |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 003 | 6 | 7/27/2022 | NON-COMPETING CONTINUATION | $465,304 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 005 | 5 | 8/9/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $29,225 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 002 | 5 | 7/12/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $0 |
| 2022 | 2021 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 001 | 5 | 6/10/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $216,163 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 004 | 4 | 8/9/2022 | NON-COMPETING CONTINUATION | -$29,225 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 000 | 4 | 6/9/2022 | NON-COMPETING CONTINUATION | -$216,163 |
|
| Issue Date FY: 2021 ( Subtotal = $474,800 ) |
| 2021 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 000 | 4 | 7/30/2021 | NON-COMPETING CONTINUATION | $474,800 |
|
| Issue Date FY: 2020 ( Subtotal = $545,387 ) |
| 2020 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 000 | 3 | 8/4/2020 | NON-COMPETING CONTINUATION | $545,387 |
|
| Issue Date FY: 2019 ( Subtotal = $529,025 ) |
| 2019 | 2019 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 000 | 2 | 7/26/2019 | NON-COMPETING CONTINUATION | $529,025 |
|
| Issue Date FY: 2018 ( Subtotal = $474,800 ) |
| 2018 | 2018 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 000 | 1 | 8/9/2018 | NEW | $474,800 |
|
|